RxSight Inc
RxSight Inc (RXST) Covered Calls
No qualifying covered call setups were found for RXST in the prior session.
Read more
Running RXST covered calls helps you generate consistent income from RxSight Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on RxSight Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best RXST covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if RXST stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling RXST covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given RxSight Inc covered call is worth writing.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Income-focused investors, long-term RXST holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling RXST covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best RxSight Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile88.10% Elevated
- Market cap (M$)194
- 52 weeks high-64.75%
- 52 weeks low4.02%
- Analyst recommendationHold
3.10 - Target price$7.57
62.45% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-1.14
- EPS growth next 5 years10.56%
As of September 25, 2026
No illustrative rows to display.
As of September 25, 2026
Sell covered calls with the data behind you
Find the best RXST covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→